Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesine.
Am J Clin Oncol. 1987 Dec;10(6):507-11. doi: 10.1097/00000421-198712000-00009.
Am J Clin Oncol. 1987.
PMID: 2825508
Clinical Trial.